Acrospire Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Acrospire Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,750	Closed	-$34K	–	2706
2016 Q4	$34K	Sell	2,750 -2,075	-43%	-$25K	0.01%	1593
2016 Q3	$66K	Buy	4,825 +3,000	+164%	+$30.1K	0.04%	861
2016 Q2	$13K	Buy	+1,825	New	+$13.7K	0.01%	1694

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Acrospire Investment Management's ARIA Position: Q1 2017 in Review

Acrospire Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,750 shares — an estimated $34K sold.

Acrospire Investment Management first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $66K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Acrospire Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Acrospire Investment Management sold 2,750 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $34K.
Acrospire Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
Acrospire Investment Management's Ariad Pharmaceuticals Inc position peaked at $66K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.